Skip to content

Effect of acupuncture on clinical outcomes of patients with repeated implantation failure

Effect of acupuncture on clinical outcomes of IVF-ET in patients with repeated implantation failure: a multicenter randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042827
Enrollment
Unknown
Registered
2021-01-29
Start date
2021-01-29
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with repeated implantation failure

Interventions

Sponsors

Obstetrics and Gynecology Hospital of Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Meet any of the following: 1) More than 3 times of embryo transfer failed, and at least 4 high-quality embryos were transferred; 2) Two consecutive embryo transfer failures, and at least 4 high quality embryos were transferred. 2. IVF / ICSI / PGD for embryo transfer; 3. 1-2 high-quality embryos at D3 cleavage stage or blastocysts will be transffered for IVF or ICSI, and only one blastocyst will be transferred from PGD; 4. Aged 20-38 years; 5. Sign informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1. Those who have contraindications to pregnancy or assisted reproductive technology; 2. Chromosomal abnormalities of either spouse (except polymorphism); 3. Abnormal gene diseases via PGD examination; 4. Untreated uterine diseases (uterine malformation, submucous myoma, adenomyosis, endometriosis, etc.) which affect the shape of uterine cavity; 5. AMH < 1.1ng/ml or AFC < 7; 6. The endometrial thickness on the day of transformation/ovulation less than 7 mm; 7. More than 2 times of clinical pregnancy abortion; 8. Patients with serious primary diseases in cardiovascular, liver, kidney, and hematopoietic system, or with mental diseases; 9. Those who have been given treatment (such as acupuncture and Traditional Chinese Medicine) related to regulating menstruation and helping pregnancy in the lateset 3 months.

Design outcomes

Primary

MeasureTime frame
Clinical pregnancy rate;live birth rate;

Secondary

MeasureTime frame
Embryo implantation rate;Biochemical pregnancy rate;Early pregnancy loss rate;ongoing pregnancy rate;Pulsatility index of uterine artery;Resistance index of uterine artery;endometrial and subendometrial blood flow;

Countries

China

Contacts

Public ContactXiaoxi Sun, Yigong Fang

Obstetrics and Gynecology Hospital of Fudan University

xiaoxi_sun@aliyun.com+86 13671992979

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026